• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖患者口服混合试验餐时血浆生长抑素和血管活性肠肽的反应。

Plasma somatostatin and vasoactive intestinal polypeptide responses to an oral mixed test meal in obese patients.

作者信息

Barreca T, Franceschini R, Messina V, Cataldi A, Salvemini M, Rolandi E

机构信息

Scientific Institute of Internal Medicine, University of Genoa, Italy.

出版信息

Horm Res. 1989;31(5-6):234-7. doi: 10.1159/000181123.

DOI:10.1159/000181123
PMID:2575574
Abstract

Ten obese and 10 control subjects were studied in basal conditions and after ingestion of a standard mixed test meal. Blood glucose, insulin, somatostatin (SLI) and vasoactive intestinal polypeptide (VIP) concentrations were determined before and 30, 60, 90, 120, 180 and 240 min after the start of the meal. Basal SLI levels in the obese (14.4 +/- 0.7 ng/l) were not significantly different from those in the controls (15.5 +/- 0.8 ng/l), whereas after the meal a blunted secretory response was recorded. Baseline plasma VIP levels were higher in the obese (29.7 +/- 1.5 ng/l) than in the control subjects (19.8 +/- 1.3 ng/l) and, similarly to the controls, were unaffected by meal ingestion. Data suggest that in the course of obesity an enhanced VIP secretion in association with a diminished SLI responsiveness to meals occurs.

摘要

对10名肥胖受试者和10名对照受试者在基础状态下以及摄入标准混合测试餐后进行了研究。在进餐开始前以及开始后30、60、90、120、180和240分钟测定血糖、胰岛素、生长抑素(SLI)和血管活性肠肽(VIP)浓度。肥胖受试者的基础SLI水平(14.4±0.7 ng/l)与对照受试者(15.5±0.8 ng/l)无显著差异,而餐后记录到分泌反应减弱。肥胖受试者的基线血浆VIP水平(29.7±1.5 ng/l)高于对照受试者(19.8±1.3 ng/l),并且与对照受试者一样,不受进餐摄入的影响。数据表明,在肥胖过程中,会出现与生长抑素对进餐反应性降低相关的血管活性肠肽分泌增强。

相似文献

1
Plasma somatostatin and vasoactive intestinal polypeptide responses to an oral mixed test meal in obese patients.肥胖患者口服混合试验餐时血浆生长抑素和血管活性肠肽的反应。
Horm Res. 1989;31(5-6):234-7. doi: 10.1159/000181123.
2
Plasma somatostatin response to an oral mixed test meal in cirrhotic patients.
J Hepatol. 1991 Jan;12(1):40-4. doi: 10.1016/0168-8278(91)90906-r.
3
Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.低剂量生长抑素输注对瘦型和肥胖型非糖尿病人体胰腺和胃内分泌功能的影响。
Diabetes. 1985 Jun;34(6):595-601. doi: 10.2337/diab.34.6.595.
4
Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.胰岛素对非胰岛素依赖型糖尿病患者空腹及进餐刺激下生长抑素样免疫反应性的影响:多种作用机制的证据
J Clin Endocrinol Metab. 1986 Jan;62(1):77-83. doi: 10.1210/jcem-62-1-77.
5
Changes in postprandial release patterns of gastrointestinal hormones in late pregnancy and the early postpartum period.妊娠晚期及产后早期胃肠激素餐后释放模式的变化。
Br J Obstet Gynaecol. 1988 Jun;95(6):565-70. doi: 10.1111/j.1471-0528.1988.tb09484.x.
6
Effects of test meal, intragastric nutrients, and intraduodenal bile on plasma concentrations of immunoreactive somatostatin and vasoactive intestinal peptide in dogs.试验餐、胃内营养物质及十二指肠内胆汁对犬血浆免疫反应性生长抑素和血管活性肠肽浓度的影响。
Gastroenterology. 1980 Nov;79(5 Pt 1):844-52.
7
The effect of oral glucose, protein, fat and water loading on blood pressure and the gastrointestinal peptides VIP and somatostatin in hypertensive elderly subjects.口服葡萄糖、蛋白质、脂肪和水负荷对老年高血压患者血压及胃肠肽血管活性肠肽和生长抑素的影响。
Eur J Clin Invest. 1990 Apr;20(2):192-8. doi: 10.1111/j.1365-2362.1990.tb02268.x.
8
Effect of intraduodenal bile and taurodeoxycholate on exocrine pancreatic secretion and on plasma levels of vasoactive intestinal polypeptide and somatostatin in man.十二指肠内胆汁和牛磺脱氧胆酸对人体胰腺外分泌及血管活性肠肽和生长抑素血浆水平的影响。
Pancreas. 1994 Jan;9(1):109-16. doi: 10.1097/00006676-199401000-00016.
9
[Relation between pyloric dysmotility and serum levels of gastrin, somatostatin and vasoactive intestinal polypeptide in patients with non-insulin dependent diabetes mellitus].[非胰岛素依赖型糖尿病患者幽门动力障碍与血清胃泌素、生长抑素及血管活性肠肽水平的关系]
Med Pregl. 1995;48(5-6):149-51.
10
Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men.肥胖男性的血浆生长抑素样免疫活性及生长抑素-28水平
J Endocrinol Invest. 1998 Jan;21(1):20-3. doi: 10.1007/BF03347281.

引用本文的文献

1
Frequency and Causes of False-Positive Elevated Plasma Concentrations of Fasting Gut Hormones in a Specialist Neuroendocrine Tumor Center.在一家神经内分泌肿瘤专科中心,空腹肠激素血浓度升高的假阳性频率和原因。
Front Endocrinol (Lausanne). 2020 Dec 16;11:606264. doi: 10.3389/fendo.2020.606264. eCollection 2020.
2
Vasoactive Intestinal Peptide Deficiency Is Associated With Altered Gut Microbiota Communities in Male and Female C57BL/6 Mice.血管活性肠肽缺乏与雄性和雌性C57BL/6小鼠肠道微生物群落改变有关。
Front Microbiol. 2019 Dec 2;10:2689. doi: 10.3389/fmicb.2019.02689. eCollection 2019.
3
Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men.
肥胖男性的血浆生长抑素样免疫活性及生长抑素-28水平
J Endocrinol Invest. 1998 Jan;21(1):20-3. doi: 10.1007/BF03347281.